The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
KEAP1 mutations in squamous cell lung cancer.
 
Sophia Koleczko
No Relationships to Disclose
 
Axel Hillmer
Research Funding - Dracen
 
Abdel Hakim Bayarassou
No Relationships to Disclose
 
Christian Grohé
Honoraria - AstraZeneca; Boehringer Ingelheim; Lilly; MSD Oncology; Novartis; Roche; Takeda
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; MSD Oncology
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; Roche
 
Martin Buchenroth
No Relationships to Disclose
 
Britta Kaminsky
No Relationships to Disclose
 
Clemens Schulte
No Relationships to Disclose
 
Sebastian Yves Friedrich Michels
No Relationships to Disclose
 
Diana Schaufler
Consulting or Advisory Role - Abbvie; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Novartis; Roche
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Novartis; Roche
 
Anna Kron
No Relationships to Disclose
 
Richard Riedel
No Relationships to Disclose
 
Theresa Westphal
No Relationships to Disclose
 
Jan-Phillip Weber
No Relationships to Disclose
 
Rieke Nila Fischer
Honoraria - Roche
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Mediolanum Farmaceutici
 
Sabine Merkelbach-Bruse
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - AstraZeneca; Bayer; GlaxoSmithKline; Molecular Health; MSD; Novartis; Pfizer; Roche; Targos GmbH
 
Lucia Nogova
Honoraria - Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Pfizer; Roche; Takeda
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen; Novartis; Pfizer; Roche; Takeda
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Celgene; Janssen; Novartis; Pfizer
 
Reinhard Buettner
Stock and Other Ownership Interests - Targovax
Consulting or Advisory Role - AbbVie; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Illumina; Lilly; MSD; Novartis; Pfizer; Qiagen; Roche
Expert Testimony - MSD
 
Juergen Wolf
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Ignyta; Janssen; Lilly; Loxo; MSD; Novartis; Pfizer; Roche; Seagen; Takeda
Research Funding - Bristol-Myers Squibb; Janssen; Novartis; Pfizer
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bayer; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Ignyta; Janssen; Lilly; Loxo; MSD; Novartis; Pfizer; Roche; Seagen; Takeda
 
Matthias Scheffler
Consulting or Advisory Role - Amgen; Boehringer Ingelheim; Novartis; Pfizer; Roche; Takeda
Research Funding - Amgen; Bristol-Myers Squibb; Dracen; Janssen; Novartis
Travel, Accommodations, Expenses - Boehringer Ingelheim